Skip to main content
. 2016 Dec;19(8):913–920. doi: 10.1016/j.jval.2016.04.014

Fig. 4.

Fig. 4

“Dominant” rotavirus vaccine in Argentina identified via ProVac economic evaluations. DALY, disability-adjusted life-year; GDP, gross domestic product; RV1 and RV5, rotavirus vaccines.